Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Raman

Showing results (211-220 of 455) with videos related to

Pageof 46
Sort By:
Journal of Managed Care Pharmacy : JMCP|September 28, 2011
Determinants of medicare all-cause costs among elderly patients with renal cell carcinomaChristopher S Hollenbeak, Lucas E Nikkel, Eric W Schaefer, et al.
International Urology and Nephrology|June 12, 2019
Accuracy of the NSQIP risk calculator for predicting complications following adrenalectomyJeffrey B Walker, Augustyna Gogoj, Brian D Saunders, et al.
Urologic Oncology|March 16, 2016
Enhancer of zeste homolog 2 (EZH2) expression in bladder cancerJoshua I Warrick, Jay D Raman, Matthew Kaag, et al.
JCO Oncology Practice|July 9, 2021
Potential Winners and Losers: Understanding How the Oncology Care Model May Differentially Affect HospitalsJoel E Segel, Eric W Schaefer, Nicholas G Zaorsky, et al.
Urologic Oncology|February 21, 2021
Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?R Grant Owens, Justin Loloi, Erik B Lehman, et al.
The Journal of Urology|March 8, 2023
Diagnostic Imaging in the Evaluation of Asymptomatic Microhematuria: Systematic Review and Meta-analysisJacob I Taylor, Lesley H Souter, Daniel A Barocas, et al.
The Canadian Journal of Urology|April 15, 2008
Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomesJay D Raman, James Thomas, Steven M Lucas, et al.
Annals of Diagnostic Pathology|June 28, 2024
Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experienceYong Zhang, Qingqing Wu, Joshua I Warrick, et al.
Journal of Kidney Cancer and VHL|September 21, 2020
Histologic Heterogeneity of Extirpated Renal Cell Carcinoma Specimens: Implications for Renal Mass BiopsyLauren M Nahouraii, Jordan L Allen, Suzanne B Merrill, et al.
Urologic Oncology|August 14, 2025
Utilization of genetic evaluation in patients with kidney cancer who meet guidelines for genetic referralElizaveta Makarova, Katrina Bakhl, Seyma Demirsoy, et al.
Pageof 46

Showing results (211-220 of 455) with videos related to

Sort By:
Pageof 46
Journal of Managed Care Pharmacy : JMCP|September 28, 2011
Determinants of medicare all-cause costs among elderly patients with renal cell carcinomaChristopher S Hollenbeak, Lucas E Nikkel, Eric W Schaefer, et al.
International Urology and Nephrology|June 12, 2019
Accuracy of the NSQIP risk calculator for predicting complications following adrenalectomyJeffrey B Walker, Augustyna Gogoj, Brian D Saunders, et al.
Urologic Oncology|March 16, 2016
Enhancer of zeste homolog 2 (EZH2) expression in bladder cancerJoshua I Warrick, Jay D Raman, Matthew Kaag, et al.
JCO Oncology Practice|July 9, 2021
Potential Winners and Losers: Understanding How the Oncology Care Model May Differentially Affect HospitalsJoel E Segel, Eric W Schaefer, Nicholas G Zaorsky, et al.
Urologic Oncology|February 21, 2021
Is pelvic MRI imaging sufficient cross-sectional imaging for staging intermediate and high-risk prostate cancer?R Grant Owens, Justin Loloi, Erik B Lehman, et al.
The Journal of Urology|March 8, 2023
Diagnostic Imaging in the Evaluation of Asymptomatic Microhematuria: Systematic Review and Meta-analysisJacob I Taylor, Lesley H Souter, Daniel A Barocas, et al.
The Canadian Journal of Urology|April 15, 2008
Radiofrequency ablation for T1a tumors in a solitary kidney: promising intermediate oncologic and renal function outcomesJay D Raman, James Thomas, Steven M Lucas, et al.
Annals of Diagnostic Pathology|June 28, 2024
Clinicopathological risk factors associated with tumor relapse of upper tract urothelial carcinoma after radical nephroureterectomy: A single institution 20-year experienceYong Zhang, Qingqing Wu, Joshua I Warrick, et al.
Journal of Kidney Cancer and VHL|September 21, 2020
Histologic Heterogeneity of Extirpated Renal Cell Carcinoma Specimens: Implications for Renal Mass BiopsyLauren M Nahouraii, Jordan L Allen, Suzanne B Merrill, et al.
Urologic Oncology|August 14, 2025
Utilization of genetic evaluation in patients with kidney cancer who meet guidelines for genetic referralElizaveta Makarova, Katrina Bakhl, Seyma Demirsoy, et al.
Pageof 46